Our Chief Business and Investment Officer and CEO are attending and presenting at the Jefferies Healthcare Conference &
LSX Inv€$tival Showcase.
The Jefferies Healthcare Conference and LSX Inv€$tival Showcase meetings directly connect life science and healthcare corporates to global capital and deal-makers.
Rowan Garnder, CBIO, PrecisionLife will present on the Healthtech and Techbio stage at 10:45am on Monday 13 November.
To see the agenda and register, visit the LSX website.
PrecisionLife focuses on precision medicine analytics in complex chronic diseases, including CNS, autoimmune, cardiovascular, respiratory and metabolic diseases. We have multiple strategic R&D collaborations with biopharma companies, and have generated deep disease insights in 50 diseases.
We map novel targets to specific patient subgroups with causal genetic and mechanistic explanations and disease prelevance. Our patient stratification biomarkers help design smaller, faster, more targeted clinical trials and to build highly predictive complementary diagnostics. We also work with biopharma companies to reevaluate clinical trial results, identify secondary indications and out-licensing opportunities for pipeline and/or stalled assets.
Contact us to learn more about PrecisionLife